Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling

Approximately 30% of epileptic patients develop Drug-Resistant Epilepsy. Based on evidence that shows a loss of efficacy in some sodium channel blocker antiseizure drugs in epilepsy, we focus our study on assessing the anticonvulsant efficacy of different sodium channel blockers on carbamazepine (CB...

Full description

Bibliographic Details

Published in:	Brain Sciences
Main Authors:	Cecilia Zavala-Tecuapetla, Joaquín Manjarrez-Marmolejo, Josué Orlando Ramírez-Jarquín, Claudia Verónica Rivera-Cerecedo
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	Drug-Resistant Epilepsy pentylenetetrazole carbamazepine anticonvulsant effect lamotrigine eslicarbazepine
Online Access:	https://www.mdpi.com/2076-3425/12/5/629